Response to Zanders et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366. (2014)

First Author: Bordeleau L

Attributed to: Preparing MethodBox for National Service funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/dc14-1567

PubMed Identifier: 25249683

Publication URI: http://europepmc.org/abstract/MED/25249683

Type: Journal Article/Review

Volume: 37

Parent Publication: Diabetes care

Issue: 10

ISSN: 0149-5992